MEDICATION RISK STRATIFICATION BY CAREKINESIS Trademark

Trademark Overview

On Wednesday, July 16, 2014, a trademark application was filed for MEDICATION RISK STRATIFICATION BY CAREKINESIS with the United States Patent and Trademark Office. The USPTO has given the MEDICATION RISK STRATIFICATION BY CAREKINESIS trademark a serial number of 86338672. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, November 24, 2015. This trademark is owned by CareKinesis, Inc. The MEDICATION RISK STRATIFICATION BY CAREKINESIS trademark is filed in the Advertising, Business and Retail Services category with the following description:

Pharmaceutical cost management services and drug utilization review services
medication risk stratification by carekinesis

General Information

Serial Number86338672
Word MarkMEDICATION RISK STRATIFICATION BY CAREKINESIS
Filing DateWednesday, July 16, 2014
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, November 24, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 23, 2014

Trademark Statements

Goods and ServicesPharmaceutical cost management services and drug utilization review services

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, July 23, 2014
Primary Code035
First Use Anywhere DateFriday, December 5, 2014
First Use In Commerce DateFriday, December 5, 2014

Trademark Owner History

Party NameCareKinesis, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMoorestown, NJ 08057
Party NameCareKinesis, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMoorestown, NJ 08057

Trademark Events

Event DateEvent Description
Wednesday, November 25, 2015ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, November 24, 2015ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, April 15, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 15, 2015NON-FINAL ACTION E-MAILED
Wednesday, April 15, 2015SU - NON-FINAL ACTION - WRITTEN
Saturday, April 11, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 10, 2015STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 3, 2015USE AMENDMENT FILED
Friday, April 10, 2015EXTENSION 1 GRANTED
Tuesday, March 3, 2015EXTENSION 1 FILED
Wednesday, April 8, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 3, 2015TEAS EXTENSION RECEIVED
Tuesday, March 3, 2015TEAS STATEMENT OF USE RECEIVED
Tuesday, February 17, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 23, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 23, 2014PUBLISHED FOR OPPOSITION
Wednesday, December 3, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 19, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 12, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 12, 2014EXAMINER'S AMENDMENT ENTERED
Wednesday, November 12, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 12, 2014EXAMINERS AMENDMENT E-MAILED
Wednesday, November 12, 2014EXAMINERS AMENDMENT -WRITTEN
Thursday, November 6, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 6, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 4, 2014ASSIGNED TO LIE
Monday, November 3, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 30, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 30, 2014NON-FINAL ACTION E-MAILED
Thursday, October 30, 2014NON-FINAL ACTION WRITTEN
Tuesday, October 28, 2014ASSIGNED TO EXAMINER
Wednesday, July 23, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 19, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

carekinesis stratification risk medication services utilization review drug pharmaceutical management cost